Depression in schizophrenia: The influence of the different dimensions of insight

Abstract

Improving insight in patients with schizophrenia appears necessary to enhance medication adherence and clinical outcome, but in some patients acquiring insight can paradoxically increase hopelessness, depression and suicidal behavior. The aim of this study is to explore the association of two dimensions of insight (cognitive and clinical) with depression, hopelessness and clinical variables in patients with psychosis. Using a cross-sectional design, 61 remitted outpatients meeting DSM-IV criteria for schizophrenia or schizoaffective disorders were included. Insight was assessed using the "Scale to Assess Unawareness of Mental Disorder" (SUMD), the PANSS-item G12 and the Beck Cognitive Insight Scale (BCIS). Overall, 41.2% of the sample had a history of suicide attempts. Patients in the high clinical insight group had significantly higher depression scores, higher hopelessness scores, greater histories of suicide attempts and were more likely to have received psychoeducation. Compared to patients with low cognitive insight, those with high overall cognitive insight were significantly more depressed and had more often received psychoeducation. Greater insight may have negative consequences in terms of depressive symptoms and therefore presents a challenge to clinicians in assessing the individual risks and benefits of strategies intended to enhance awareness of mental disorder.

Introduction

Lack of insight is a common feature of schizophrenia (Amador et al., 1994). It has an important impact on several markers of clinical outcome. In particular, studies have demonstrated that lack of insight is linked to greater overall severity of psychopathology (Mintz et al., 2003, Mutsatsa et al., 2006) and to poorer medication adherence, which is in turn associated with more frequent relapses and hospitalizations (Llorca, 2008, Acosta et al., 2009, Velligan et al., 2009). By contrast, several studies show that greater insight is related to increased depression (Amador et al., 1994, Mintz et al., 2003, Mutsatsa et al., 2006, Mohamed et al., 2009), lower quality of life (Staring et al., 2009) as well as poorer subjective well-being (Valiente et al. 2011). Insight has also been linked to suicidal behavior (Drake and Cotton, 1986, Crumlish et al., 2005). Concerning the mechanisms underlying this association, some researchers have hypothesized that suicide risk may be mediated by depression or hopelessness levels (Kim et al., 2003, Bourgeois et al., 2004, López-Moríñigo et al., 2012). Although it is possible to improve insight while also reducing depression, such as by assisting persons to cope with awareness of illness and stigma through psychoeducation and family interventions (Lysaker et al., 2006, Brent et al., 2011), the risks and benefits of insight remain complex and providing an individualized therapeutic strategy presents particular challenges for the clinician.

Current theories of insight have drawn support from a variety of studies, but a comprehensive conceptual model has yet to be proposed (Osatuke et al., 2008). While this construct is often assessed by single items from broader instruments such as the Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987), a multidimensional conceptualization of this construct has developed over the last 20 years in which insight is considered to exist on a continuum relative to on the patient׳s awareness. This multidimensional conceptualization of clinical insight is perhaps best illustrated by the Scale to assess Unawareness of illness in Mental Disorders (SUMD) (Amador et al., 1993). However, Beck and colleagues proposed the complementary concept of cognitive insight, defined as a patient׳s current capacity to evaluate their anomalous experiences and their specific misinterpretations of events. This conceptualization of insight contributed to the validation of the Beck Cognitive Insight Scale (BCIS) (Beck et al., 2004).

In light of its seemingly contradictory effects, insight is a complex phenomenon with uncertain determinants and that challenges clinicians to develop therapeutical startegies tailored to the individual. This investigation examines both clinical and cognitive insight in a sample of remitted outpatients with schizophrenia seen at regularly-scheduled consultations. The aim is to explore how each insight dimension is associated with hopelessness and suicidal behavior, as well as to examine if both dimensions differ among patients who received psychoeducation.